The embolization coil refers to endovascular intervention technique used for treatment of
intracranial ruptured or unruptured aneurysms and other disorders. The swift development of embolization techniques have permitted endovascular treatment to be applied on more complex aneurysms those were initially impossible to treat via traditional endovascular techniques.
The Embolization Coil market has witnessed a growth from USD XX million to USD XX million from 2017 to 2022. With a CAGR of X.X%, this market is estimated to reach USD XX million in 2029.

The report focuses on the Embolization Coil market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Embolization Coil market.

Major Players in the Embolization Coil market are:
St. Jude Medical
DePuy Synthes
Medtronic
Cordis Corporation
Boston Scientific Corporation
Terumo Corporation
Stryker Corporation
Sirtex medical
Cook Medical

On the basis of types, the Embolization Coil market is primarily split into:
Pushable
Detachable

On the basis of applications, the market covers:
Neurology
Oncology
Urology
Peripheral Vascular Disease

Major Region

s or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others

Years considered for this report:

Historical Years:

2017-2021

Base Year:

2021

Estimated Year:

2022

Forecast Period:

2022-2029